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Background: Magnolia grandiflora L. flower is wildly used in Asian as a traditional herbal medication. The purpose
of the study was to investigate the antimelanogenic and antioxidant properties of Magnolia grandiflora L. flower
extract. In the study, the inhibitory effects of M. grandiflora L. flower extract on mushroom tyrosinase, B16F10
intracellular tyrosinase activity and melanin content were determined spectrophotometrically. Meanwhile, the
antioxidative capacity of the flower extract was also investigated.
Results: Our results revealed that M. grandiflora L. flower extract inhibit mushroom tyrosinase activity (IC50 =11.1%;
v/v), the flower extract also effectively suppressed intracellular tyrosinase activity (IC50 = 13.6%; v/v) and decreased
the amount of melanin (IC50 = 25.6%; v/v) in a dose-dependent manner in B16F10 cells. Protein expression level of
tyrosinase and tyrosinase-related protein 1 (TRP-1) were also decreased by the flower extract. Additionally,
antioxidant capacities such as ABTS+ free radical scavenging activity, reducing capacity and total phenolic content
of the flower extract were increased in a dose-dependent pattern.
Conclusions: Our results concluded that M. grandiflora L. flower extract decreased the expression of tyrosinase and
TRP-1, and then inhibited melanogenesis in B16F10 cells. The flower extract also show antioxidant capacities and
depleted cellular reactive oxygen species (ROS). Hence, M. grandiflora L. flower extract could be applied as a type of
dermatological whitening agent in skin care products.
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Melanin plays an important role in protection the skin
against ultraviolet light injury and is responsible for
skin color. However, overproduction and accumulation
of melanin result in several skin disorders including
freckles, melasma, age spots and other hyperpigmenta-
tion syndrome [1]. Tyrosinase (monophenol, L-dihydrox-
yphenylalanine (L-DOPA): oxygen oxidoreductase EC
1.14.18.1) is the key enzyme in the first two steps of
melanin biosynthesis, in which L-tyrosine is hydroxylated
to L-DOPA (o-diphenol product), and L-DOPA is further
oxidized into the corresponding o-quinone [2]. It has
been reported that microphthalmia-associated transcriotion* Correspondence: ctm@sunrise.hk.edu.tw
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reproduction in any medium, provided the orfactor (MITF) and other enzymes such as tyrosinase
related protein-1 (TRP-1) and tyrosinase related protein-2
(TRP-2) also contribute to the production of melanin
[3-5]. Recently, melanogenesis inhibitors have been in-
creasingly applied in skin care cosmetics for the preven-
tion of hyperpigmentation [6]. In addition, melanogenesis
is reported to produce hydrogen peroxide (H2O2) and
other reactive oxygen species (ROS) which makes the mel-
anocytes under high-grade oxidative stress. It is well
known that ROS play a significant role in the regulation of
the melanogenesis, while ROS scavengers and inhibitors of
ROS generation may down-regulate UV-induced melano-
genesis [7]. Therefore, antioxidants such as ascorbic deri-
vatives and reduced glutathione (GSH) have been applied
as inhibitory agents of melanogenesis [8,9].
Magnolia grandiflora L. (Magnoliaceae) is widely used
as a traditional medicine for the treatment of diarrhea, ab-
dominal diseases, rheumatic arthritis, heart disturbances,Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Effect of M. grandiflora L. flower extract on B16F10
cell viability. Cells were treated with various concentration of flower
extract (10, 12.5, 15, 17.5, 20%; v/v) for 24 h and the cell viability was
measured by MTT assay. Results are expressed as percentage of cell
viability relative to control. Data are presented as mean± S.D. Values
are significantly different by comparison with control. ** p< 0.01.
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aqueous extracts of flowers and leaves have been reported
to exhibit cardiovascular effects [11] and was also used
as an anticonvulsant in rat [12]. Chemical studies on M.
grandiflora L. and other plants of the same genus, such as
M. officinalis, have reported the presence of magnolol and
honokiol [13,14], which exhibit muscle relaxant activity
[15], inhibitory effects on skin tumour promotion [16] and
antimicrobial properties [17]. It is interesting to find that
M. grandiflora L. contains a number of sesquiterpene lac-
tones which possess anti-inflammatory properties and
used for treatment of pain [18]. A number of biologically
active alkaloids [14], sesquiterpenes [19], phenolic consti-
tuents [17], glycosides [20] and other compounds [21]
have been isolated from this species. However, scientific
studies of the antimelanogenic and antioxidant properties
of this medicinal plant are lacking.
The aim of this study was to investigate the inhibitory
effects of M. grandiflora L. flower extracts on mushroom
tyrosinase activity, murine intracellular tyrosinase activ-
ity, expression of melanogenesis-related proteins and
melanin content in B16F10 melanoma cells, as well as its
antioxidant activities.Results
Effect of M. grandiflora L. flower extract on B16F10 cell
viability
The MTT assay was used to assess the effect of M.
grandiflora L. flower extract on B16F10 melanoma cells
viability. The cells were treated with various concentra-
tions of the flower extract (10, 12.5, 15, 17.5, 20%; v/v) for
24 h and then MTT assay was performed. Results are
expressed as percent viability relative to control. After
treatment, M. grandiflora L. flower extract show no cyto-
toxic effect on B16F10 cell proliferation (Figure 1).Effect of M. grandiflora L. flower extract on mushroom
tyrosinase activity, B16F10 melanin content and
intracellular tyrosinase activity
In order to assay the inhibitory effect of the flower ex-
tract on mushroom tyrosinase activity, tyrosinase enzyme
inhibition experiments were carried out in triplicate. The
results indicated that mushroom tyrosinase activity was
inhibited by the various concentrations of M. grandiflora
L. flower extract. The remained tyrosinase activity was
48.14 ± 7.92%, 41.32 ± 5.90% and 38.75 ± 8.5% of control
for 10, 15 and 20% (v/v) of the flower extract, respect-
ively. The IC50 of the flower extract on mushroom tyro-
sinase is 11.1% (v/v). Meanwhile, mushroom tyrosinase
activity was also inhibited by kojic acid (200 μM) and
remained enzyme activity was 29.21 ± 3.12% of that of
control (Figure 2A). Hence, M. grandiflora L. flower ex-
tract may act as a tyrosinase inhibitor.To determine the antimelanogenic activity of M.
grandiflora L. flower extract, the inhibitory effect of the
flower extract on melanin content in B16F10 melanoma
cells was assayed. B16F10 cells were first stimulated with
α-MSH (100 nM) for 24 h, and then cultured in the
presence of the flower extract at 10, 15 and 20% (v/v) or
arbutin (2.0 mM), respectively. Treatment with the
flower extract showed a significant inhibitory effect on
melanin synthesis in a dose-dependent pattern. The mel-
anin content was represented as percentage of control.
After treatment, the melanin content was 83.22 ± 0.64%,
70.49 ± 2.23% and 62.48 ± 2.10% for 10, 15 and 20% (v/v)
of the flower extract, respectively (Figure 2B). The IC50
of the flower extract on B16F10 melanin content is
25.6% (v/v). Meanwhile, B16F10 cells were treated with
arbutin (2.0 mM) as positive standard, and the remained
intracellular melanin content was 73.34 ± 1.00% of con-
trol for arbutin.
To examine the action mechanism of the inhibitory ef-
fect of M. grandiflora L. flower extract on melanogenesis
more precisely, we assessed intracellular tyrosinase activ-
ity in B16F10 melanoma cells. The cells were first stimu-
lated with α-MSH (100 nM) for 24 h, and then cultured
with various concentrations of the flower extract (10, 15,
20%; v/v) or arbutin (2.0 mM) for another 24 h. The
flower extract significantly inhibited α-MSH-induced tyro-
sinase activity in a dose-dependent pattern. After these
treatments, the remaining intracellular tyrosinase activity
was 72.80± 2.30%, 32.28± 2.35% and 24.61± 1.16% for 10,
15 and 20% (v/v) of the flower extract, respectively. The
IC50 of the flower extract on B16F10 intracellular tyrosin-
ase is 13.6% (v/v). Meanwhile, the intracellular tyrosinase
Figure 2 Inhibitory effect of M. grandiflora L. flower extract on
mushroom tyrosinase activity, B16F10 melanin content and
intracellular tyrosinase actvity. (A) Different concentrations of the
flower extract (10, 15, 20%; v/v) or kojic acid (200 μM) was incubated
with the same units of mushroom tyrosinase. Following incubation,
the amount of dopachrome produced was determined at 490 nm
spectrophotometrically. (B) & (C) B16F10 melanoma cells were
stimulated with α-MSH (100 nM) for 24 h, and then the melanin
content or intracellular tyrosinase activity were measured after
treatment with various concentrations of the flower extract (final
concentration 10, 15, 20%; v/v) or arbutin (2.0 mM) for another 24 h.
Results are represented as percentages of control, and data are
presented as mean± S.D. for three separate experiments. Values are
significantly different by comparison with control. *** p< 0.001.
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arbutin (2.0 mM) (Figure 2C).
Effect of M. grandiflora L. flower extract on expression of
melanogenesis-related proteins
To test whether M. grandiflora L. flower extract does
regulate the expression of melanogenesis-related pro-
teins, B16F10 melanoma cells were treated with α-MSH
(100 nM) for 24 h, and then 10, 15, and 20% (v/v) of M.
grandiflora L. flower extract or kojic acid (200 μM) was
added for another 24 h. MITF, tyrosinase, TRP-1, and
TRP-2 levels were assayed by Western blot (Figure 3A).
It was found that M. grandiflora L. flower extract treat-
ment led to a reduced level of tyrosinase and TRP-1
(Figure 3B), but the protein contents of MITF and TRP-2
were not obviously changed after treatment (Figure 3A).
Antioxidant capacities of M. grandiflora L. flower extract
The ABTS+ assay was first employed to measure the anti-
oxidant activity of the flower extract of M. grandiflora L.
Different concentrations of the flower extract (final con-
centration 10, 15, 20%; v/v), Vitamin C (50 μM), Vitamin E
(50 μM) or BHA (0.1 mg/ml) were incubated with ABTS+
solution, respectively. The ABTS+ scavenging capacity of
the flower extract was 22.15± 1.07%, 29.06 ± 1.73% and
32.49± 1.92% of control for the flower extract at the con-
centration of 10, 15 and 20% (v/v), respectively. Mean-
while, the ABTS+ scavenging capacity of Vitamin C,
Vitamin E and BHA was 92.19± 0.28%, 60.13 ± 2.48%,
85.29± 0.58%, respectively. The results indicated that the
flower extract of M. grandiflora L. scavenges ABTS+ free
radical significantly in a dose-dependent manner. How-
ever, the flower extract show lower ABTS+ radical scaven-
ging capacity than Vitamin C, Vitamin E or BHA do
(Figure 4A).
To determine the amount of total phenolic contents of
M. grandiflora L. flower extract (10, 15, 20%; v/v), gallic
acid (2 μg/ml) was used as positive standard. The results
in Figure 4B showed that the total phenolic contents in
10, 15 and 20% (v/v) of M. grandiflora L. flower extract
Figure 3 Effect of M. grandiflora L. flower extract on melanogenesis-related proteins expression. (A) B16F10 cells were cultured with
α-MSH (100 nM) for 24 h and then treated with various concentration of the flower extract (10, 15, 20%; v/v) or kojic acid (200 μM) for another 24
hr. Then the content of cellular MITF, tyrosinase, TRP-1 and TRP-2 proteins were analyzed by western blotting assay. (B) The relative amounts of
MITF, tyrosinase, TRP-1 and TRP-2 compared to total GAPDH were calculated and analyzed by Multi Gauge 3.0 software and the values
represented the mean of triplicate experiments ± S.D.
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ively. The phenolic content of 20% (v/v) of flower extract
was similar to that of gallic acid (73.52 ± 0.19%).
To determine the reducing capacity of M. grandiflora L.
flower extract, various concentrations of the flower extract
(10, 15, 20%, v/v) or BHA (0.05 mg/ml) were tested. The
results shown in Figure 4C revealed that higher concentra-
tions of M. grandiflora L. flower extract present apparent re-
ducing power. The reducing power of 10, 15, and 20% (v/v)
of M. grandiflora L. flower extract were 26.89±1.20%,
32.20±0.48% and 36.47±1.08%, respectively.
To confirm the antioxidant capacity of M. grandiflora
L. flower extract in a cellular environment, evaluation ofintracellular ROS levels was done. The concentration of
H2O2 employed was 20 mM. After treatment, the remained
intracellular ROS induced by H2O2 was 86.53± 3.60% for
20% (v/v) of the flower extract and 87.89± 12.35% for
Trolox (2.0 mM) (Figure 4D).
Discussion
Inhibition of melanogenesis effects of M. grandiflora L.
flower extract
The MTT assay is a common colorimetric assay to meas-
ure the activity of enzymes that reduce MTT to forma-
zan dyes, giving a purple color. It can also be used to
determine the cytotoxicity of potential medicinal agents
Figure 4 Antioxidant activities of M. grandiflora L. flower extract. (A) ABTS+ radical scavenging capacity assay. The flower extract (10, 15, 20%;
v/v), vitamin C (50 μM), vitamin E (50 μM) or BHA (0.1 mg/ml) were incubated with ABTS+ solution, respectively. (B) Determination of total
phenolic content. Different concentrations of the M. grandiflora flower extract (10, 15, 20%; v/v) and gallic acid (2 μg/ml) were used in the assay.
(C) Reducing capacity assay. Different concentrations of the flower extract (10, 15, 20%; v/v) or BHA (0.05 mg/ml) were used in the test. (D)
Determination of ROS content in B16F10 cells. Cells were treated with various concentrations of the flower extract (10, 15, 20%; v/v) or Trolox (2.0
mM) for 24 h and then the ROS content was measured by the DCF-DA assay. Results are represented as percentages of control, and the data are
mean± S.D. for three separate experiments. Values are significantly different by comparison with control. *** p< 0.001.
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inhibit cell viability and growth. The results shown in
Figure 1 indicated that even higher concentration of M.
grandiflora L. flower extract (20%; v/v) also had no cyto-
toxic effect on B16F10 melanoma cell viability.
Tyrosinase plays an essential role in the first two steps
of melanin synthesis pathway. It could convert L-tyrosine
to L-DOPA and oxidizes L-DOPA to form dopachrome.
Mushroom tyrosinase is widely used as the target en-
zyme in screening potential inhibitors of melanogenesis.
The results shown in Figure 2A indicated that M. grandi-
flora L. flower extract show slightly lower inhibitory ef-
fect on mushroom tyrosinase activity than kojic acid
does. To elucidate the true inhibitory effect of the flower
extract on melanogenesis, B16F10 melanin content and
intracellular tyrosinase activity were assayed at the same
concentration range. The results shown in Figure 2B
indicated that the flower extract from M. grandiflora L.
present a stronger inhibitory effect on melanin formationin B16F10 cells than arbutin does. The data provided evi-
dence that M. grandiflora L. flower extract blocks mela-
nogenesis in B16F10 melanoma cells. The results shown
in Figure 2C were in accordance with the results indi-
cated in Figure 2B, which means the flower extract of M.
grandiflora L. inhibited B16F10 intracellular tyrosinase
activity and then decreased the melanin content in a
dose-dependent manner. In the experiments, α-MSH
was used as a cAMP inducer to stimulate melanin syn-
thesis. It is reported that α-MSH can bind melanocortin
1 receptor (MC1R) and activate adenylate cyclase, which
in turn catalyzes ATP to cAMP and increases intracellu-
lar cAMP level [22]. In the present study, the results
show that M. grandiflora L. flower extract inhibited mel-
anogenesis induced by α-MSH mediated intracellular
cAMP up-regulation.
TRP-1 and TRP-2 are two enzymes participated in
regulation of tyrosinase activity. The results shown in
Figure 3A and B indicated that M. grandiflora L. flower
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tyrosinase and TRP-1, then inhibited tyrosinase activity
and finally decreased melanin content in B16F10 cells.
MITF is well known to act as a transcritption factor of
tyrosinase. However, in our experiments, the flower ex-
tract did not affect MITF expression.
Antioxidant capacities of M. grandiflora L. flower extract
The ABTS+ free radical has been widely used as a tool to
estimate free radical scavenging activity of antioxidants.
Antioxidants, on interaction with ABTS+, either transfer
electrons or hydrogen atoms to ABTS+, thus neutralizing
the free radical character [23]. In the present study, the
flower extract showed lower free radical scavenging ac-
tivities as compared to Vitamin C, Vitamin E or BHA.
When assay the total phenolic content of M. grandiflora
L. flower extract, it was interesting to find that higher con-
centration of the flower extract (20%, v/v) has similar total
phenolic content as gallic acid does. This is probably due
to most bioactive compounds such as polyphenols includ-
ing tannins and flavonoid existed in high polar extracts
[24]. Polyphenols are one of the major plant compounds
with antioxidant activity. The antioxidant activity of phen-
olic compounds is reported to be mainly due to their
redox properties [25], which can play an important role in
adsorbing and neutralizing free radicals, quenching singlet
and triplet oxygen, or decomposing peroxides.
In the reducing power assay, it was found that the re-
ducing power of the flower extract was much lower than
that of BHA. Even though increases the concentration,
the reducing power of the flower extract was still lower
than that of BHA.
To confirm the antioxidant capacity of M. grandiflora
L. flower extract in a cellular environment, evaluation of
intracellular ROS levels was done. The principle of the
assay is that DCFH-DA diffuses through the cell mem-
brane and is enzymatically hydrolyzed by esterase to
DCFH, which reacts with ROS (such as H2O2) to yield
DCF. Rapid increases in DCF indicate oxidation of
DCFH by intracellular radicals. The results revealed the
flower extract depleted intracellular ROS in a dose-
dependent manner. The skin is exposed to UV and envir-
onmental oxidizing pollutants and is a preferred target of
oxidative stress. It is reported that ultraviolet irradiation
induce the formation of ROS in cutaneous tissue provok-
ing toxic changes such as lipid peroxidation and enzyme
inactivation [26]. To counteract the oxidative damage,
skin is equipped with a network of enzymatic and non-
enzymatic antioxidant systems.
It is reported that chronic exposure to solar UV radi-
ation plays a role in the initiation of several skin disorders,
including scaling, wrinkling, dryness and mottled pigment
abnormalities such as hypopigmentation and hyperpig-
mentation [27,28]. Therefore, there is an increasing needfor new and effective agents which perform photoprotec-
tion and skin whitening activities to prevent the above
skin disorders. So far, there is no report about the effect
of M. grandiflora L. flower extract on melanin produc-
tion. This is the first study to evidence the potential in-
hibitory effect of M. grandiflora L. flower extract on
melanogenesis in B16F10 melanoma cells. Besides, the
flower extract also show antioxidant capacities, which fit
the trend of skin whitening agents show dual functions
including anitimelanogenenic and antioxidant activities.
For example, several plants such as Paeonia suffruticosa
[29] and chestnut flower extract [30] havd been reported
to show antioxidant and antimelanogenic properties as
M. grandiflora L. flower extract did. The present results
suggested that M. grandiflora L. flower extract decreased
melanin production may be attributed to inhibition of
tyrosinase and TRP-1 or due to its depletion of cellular
ROS.
Conclusions
In the study, M. grandiflora L. flower extract show po-
tential dermatological effect against melanin production
in B16F10 melanoma cells and present antioxidant cap-
acities. This is the first report about the effect of M.
grandiflora L. flower extract on melanin production. In
the present study, it is found that M. grandiflora L.
flower extract inhibit melanin synthesis significantly in
a dose-dependent pattern. Besides, M. grandiflora L.
flower extract also expressed antioxidant activities. The
results suggested that M. grandiflora L. flower extract
decreased melanin production may be attributed to its
inhibitory action upon the signaling pathway regulating
tyrosinase activity or depletion of cellular ROS. We will
study the effects of various protein kinase inhibitors on
melanogenesis in B16F10 melanoma cells after treatment
with M. grandiflora L. flower extract in the near future.
Certainly, we will also analyze the potential active com-
ponents in the M. grandiflora L. flower extract and eluci-
date the possible whitening mechanisms.
Methods
Chemicals and reagents
Gallic acid, L-ascorbic acid (AA), Folin–Ciocalteau’s phenol
reagent, 1,1-diphenyl-2-picrylhydrazyl (DPPH), butylated
hydroxyanisole (BHA) and all other chemicals and solvents
were obtained from Sigma–Aldrich (St. Louis, MO).
Preparation of M. grandiflora L. flower extract
M. grandiflora L. fresh flowers (2 kg) were collected in May
2011 from a farm located at Jianshi township of Hsinchu
county in Taiwan. The flowers were air-dried, crushed and
added to 800 mL water at room temperature for 48 h to
yield 650 mL aqueous extract. The final aqueous extract was
stored at 4°C until use.
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B16F10 cells (ATCC CRL-6475; from the BCRC Cell Line
Bank, BCRC60031) were cultured in DMEM with 10%
fetal bovine serum (FBS; Gibco BRL, Gaithersburg, MD,
USA) and penicillin/streptomycin (100 I.U/50 μg/mL) in a
humidified atmosphere containing 5% CO2 in air at 37°C.
All the experiments were performed in triplicate and were
repeated 3 times to ensure reproducibility.
Cell proliferation assay
Cell viability assay of B16F10 was performed using 3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) [31]. In brief, 1 × 104 cells/well was seeded into a
96-well plate. The cells were exposed to various concen-
trations of M. grandiflora L. flower extract (final concen-
tration 10, 12.5, 15, 17.5, 20%; v/v) for 24 h, the MTT
solution was added to the wells. The insoluble derivative
of MTT produced by intracellular dehydrogenase was
solubilized with ethanol-DMSO (1:1 mixture solution).
The absorbance of the wells at 570 nm was read using a
microplate reader.
Assay of mushroom tyrosinase activity
In order to assay the inhibitory action of M. grandiflora
L. flower extract (final concentration 10, 15, 20%; v/v) on
mushroom tyrosinase, dose-dependent inhibition experi-
ments were carried out in triplicate, as described previ-
ously, with a minor modification [32]. Briefly, 10 μL of
aqueous solution of mushroom tyrosinase (200 units)
was added to a 96-well microplate, in a total volume of
200 μL mixture containing 5 mM L-DOPA which is dis-
solved in 50 mM phosphate buffer (pH 6.8). The assay
mixture was incubated at 37°C for 30 min. Following in-
cubation, the amount of dopachrome produced in the re-
action mixture was determined spectrophotometrically
at 490 nm (OD490) in a microplate reader. The inhibition
percentage at three doses for each experiment was calcu-
lated by the following equation: inhibition percentage of
tyrosinase activity (%) = (B-A)  A×100, where B is the
mean of the measured OD490 values of the blank control,
and A is the mean of the measured OD490 values for the
M. grandiflora L. flower extract treated group.
Measurement of melanin content
The intracellular melanin content was measured as
described by Tsuboi et al [33] with some modifications.
The cells were treated with α-MSH (100 nM) for 24 h, and
then the melanin content was determined after treatment
with either M. grandiflora L. flower extract (final concen-
tration 10, 15, 20%; v/v) or arbutin (2.0 mM) for a further
24 h. After treatment, the cells were detached by incuba-
tion in trypsin/ethylenediaminetetraacetic acid (EDTA).
After precipitation, cell pellets containing a known num-
ber of cells were solubilized in 1 N NaOH at 60°C for 60min. The melanin content was assayed by spectrophoto-
metric analysis at an absorbance of 405 nm.
Assay of B16F10 intracellular tyrosinase activity
Cellular tyrosinase activity was determined as described
previously [34] with slight modifications. Briefly, the cells
were treated with α-MSH (100 nM) for 24 h, and then
intracellular tyrosinase activity was measured after treat-
ment with various concentrations of M. grandiflora L.
flower extract (final concentration 10, 15, 20%; v/v) or
arbutin (2.0 mM) for 24 h. After these treatments, the
cells were washed twice with phosphate-buffered saline
and homogenized with 50 mM PBS (pH 7.5) buffer con-
taining 1.0 % Triton X-100 and 0.1 mM PMSF. Intracel-
lular tyrosinase activity was monitored as follows: Cell
extracts (100 μL) were mixed with freshly prepared
L-DOPA solution (0.1% in phosphate-buffered saline)
and incubated at 37°C. The absorbance at 490 nm was
measured with microplate reader Gen 5TM (BIO-TEK In-
strument, Bermont, USA) to monitor the production of
dopachrome, corrected for auto-oxidation of L-DOPA.
ABTS+ scavenging capacity assay
The ABTS decolorisation assays were carried out as previ-
ously described [35] and it involves the generation of ABTS
+ chromophore by oxidation of ABTS with potassium per-
sulfate. The ABTS radical cation (ABTS+) was produced by
reacting 7 mM stock solution of ABTS with 2.45 mM po-
tassium persulfate and allowing the mixture to stand in the
dark for at least 6 h before use. Absorbance at 734 nm was
measured 10 min after mixing of different concentrations
of the M. grandiflora L. flower extracts (final concentration
10, 15, 20 %; v/v) with 1 ml of ABTS+ solution. The ABTS+
scavenging capacity of the filtrate was compared with that
of vitamin C (50 μM) and vitamin E (50 μM).
Determination of total phenolic content
The amount of total phenolics was determined with the
Folin–Ciocalteu reagent [36]. First a standard curve was
plotted using gallic acid as a standard. Different concen-
trations of samples were prepared in 80% of methanol.
Hundred microliter of sample was dissolved in 500 μl (1/
10 dilution) of the Folin–Ciocalteu reagent and 1000 μl
of distilled water. The solutions were mixed and incu-
bated at room temperature for 1 min. After 1 min, 1500
μl of 20% sodium carbonate solution was added. The
final mixture was shaken and then incubated for 2 h in
the dark at room temperature. The absorbance of sam-
ples was measuredat 760 nm and gallic acid (2 μg/ml)
was used as standard.
Determination of reducing capacity
The reducing power of the extract was determined
according to the method of Oyaizu [37]. Different
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10, 15, 20%; v/v) or BHA (0.05 mg/ml) was mixed with
phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and potassium
ferricyanide [K3Fe(CN)6] (2.5 ml, 1% w/v). The mixture
was incubated at 50°C for 20 min. A portion (2.5 ml) of
trichloroacetic acid (10% w/v) was added to the mixture,
which was then centrifuged at 1000g for 10 min. The
upper layer of solution (2.5 ml) was mixed with distilled
water (2.5 ml) and FeCl3 (0.5 ml, 0.1% w/v), and the ab-
sorbance was measured at 700 nm in a UV-Vis spectro-
photometer. Higher absorbance of the reaction mixture
indicated greater reducing power.
Cellular ROS level determination
B16F10 melanoma cells were cultured in 24-well plates
(5 × 104 cells in 1 mL of DMEM medium) and treated
with various concentrations of M. grandiflora L. flower
extract (final concentration 10, 15, 20%; v/v) for 24 h.
The cells were then incubated with 24 mM H2O2 at 37°
C for 30 min. After incubation, 2', 7'-dichlorofluorescein
diacetate (DCFH-DA) was added to the wells, and the
cells were cultured for 30 min. After treatment, the cells
were washed with phosphate-buffered saline, and trypsi-
nized by trypsin/EDTA, and the fluorescence intensities
of DCF were measured at excitation wavelength 504 nm
and emission wavelength 524 nm using a fluorescent
reader Fluoroskan Ascent (Thermo Scientific, Vantaa,
Finland). The data were analyzed with Ascent software
(Thermo Scientific, Vantaa, Finland). Cells with increased
ROS content, appeared as a population with a higher
fluorescence intensity [38].
Western Blotting assay
B16F10 cells, treated with M. grandiflora L. flower extract
(10, 15, 20%; v/v) or kojic acid (200 μM), were washed
twice with cold phosphate-buffered saline (PBS), lysed in
PBS containing 1% Nonidet P-40, 0.5% sodium deoxycho-
late, 0.1% sodium dodecyl sulfate (SDS), 5μg/mL of aproti-
nin, 100 μg/mL of phenylmethylsulfonyl fluoride, 1 μg/mL
of pepstatin A, and 1 mM EDTA at 4°C for 20 min, and
then disrupted with a needle. Total cell lysates were
quantified using a microBCA kit. Proteins (50 μg) were
resolved by SDS-polyacrylamide gel electrophoresis and
electrophoretically transferred to a polyvinylidene fluoride
(PVDF) filter. The nylon filter was blocked for 1 h in 5%
fat-free milk in PBST buffer (PBS with 0. 05% Tween-20).
After a brief wash in the PBST buffer, the nylon filter
was incubated overnight at 4°C with antibodies (anti-
microphthalmia-associated transcription (MITF) antibody
(1:1,000), anti-TRP1 antibody (1:2,000), anti-TRP2 antibody
(1:2,000), anti-GAPDH antibody (1:3,000), and anti-tyro-
sinase antibody (1:2,000) (Epitomics, Burlingame, CA).
Then the primary antibody was removed, and the filter
was further washed extensively in PBST buffer. Subsequentincubation with goat anti-mouse antibody (1:10,000) con-
jugated with horseradish peroxidase was conducted at
room temperature for 2 h. The filter was washed exten-
sively in PBST buffer to remove the secondary antibody,
and the blot was visualized with ECL reagent. The relative
amounts of MITF and tyrosinase, compared to total
GAPDH were calculated and analyzed with Multi Gauge
3.0 software (Fuji, Tokyo).
Statistical analysis
Statistical analysis of the experimental data was per-
formed by one-way ANOVA Tukey test, which was used
for comparison of measured data using SPSS 12.0 statis-
tical software (SPSS, Chicago). Differences were consid-
ered statistically significant at p< 0.05, ** p< 0.01 and
*** p< 0.001.
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